Filing Details

Accession Number:
0000905148-24-003257
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-22 12:30:13
Reporting Period:
2024-11-21
Accepted Time:
2024-11-22 12:30:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439725 Biodesix Inc BDSX Services-Medical Laboratories (8071) 203986492
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1830773 Jr T. Lawrence Kennedy
1700 Madison Road, Suite 200
Cincinnati OH 45206
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-21 35,000 $1.16 10,411,024 No 4 P Indirect By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,267,873 Indirect By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16
Common Stock 2,775,386 Indirect By: KFDI-B LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.155 to $1.1602, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.